English / Deutsch

Profile


Enzymicals was founded in 2009 and is specialized in providing integrated solutions for biocatalytic applications. This includes the customization and the production of enzymes and their application for the making of fine and specialty chemicals.
The activity in the field of white biotechnology resulted in several cooperations and research partnerships.

Already shortly after the founding the Zwingenberg-based biotechnology company BRAIN AG recognized the potential of Enzymicals AG and acquired a minority share as a strategic investment. This strategic alliance combines the complementary modules of both companies to make up the value chain for biocatalytic production of fine and special chemicals. This national cooperation also holds other synergetic effects, e.g. for customer oriented services Enzymicals AG has access to BRAIN's extensive enzyme and metagenome libraries for screening purposes. Identified biocatalysts can then be used for the development of processes, which will be commercialized together.

Prof. Bornscheuer, Dr. Eck und Dr. Menyes unterzeichnen den Beteiligungsvertrag
Prof. Bornscheuer, Dr. Eck and Dr. Menyes sign the cooperation agreement.

After three years of existence the company got a growth financing from Braun Beteiligungs GmbH, with which, amongst others, the cooperation with Herbrand PharmaChemicals GmbH, belonging to the BBG group, should be strengthened.
Besides Herbrand PharmaChemicals GmbH, several other companies from the pharma- ceutical industry belong to the BBG network.
In cooperation with BRAIN AG and Herbrand PharmaChemicals GmbH active pharmaceutical ingredients can be developed within this network starting from the screening of suitable enzymes for production up to the marketable product.
Further on Enzymicals AG cooperates with LONZA AG to apply (R)-selective transaminases in asymmetric synthesis as well as with Greifswald-based Institute of Marine Biotechnology e.V., whereby both organizations unite their competencies in the field of alternative expression systems and functional genome analysis for the production of fine chemicals.

The enzyme catalog of Enzymicals AG contains for example patented recombinant isoenzymes of pig liver esterase, novel Baeyer-Villiger monooxygenases and (R)-selective transaminases. With these examples Enzymicals AG was able to bring enzymes from different classes to marketable products. In addition to the enzymes offered in the catalog Enzymicals is also able to identify news biocatalysts for specific reactions or to adapt existing ones to them. The resulting combination of tailor-made biocatalysts with optimized chemical and technological synthesis routes enables Enzymicals AG to expand its business along the whole value chain of the white biotechnology industry.

Aktionäre und Vorstand der Enzymicals AG
Shareholders and board of directors of Enzymicals AG.

The enzyme catalog of Enzymicals AG contains for example patented recombinant isoenzymes of pig liver esterase, novel Baeyer-Villiger monooxygenases and (R)-selective transaminases. With these examples Enzymicals AG was able to bring enzymes from different classes to marketable products. In addition to the enzymes offered in the catalog Enzymicals is also able to identify news biocatalysts for specific reactions or to adapt existing ones to them. The resulting combination of tailor-made biocatalysts with optimized chemical and technological synthesis routes enables Enzymicals AG to expand its business along the whole value chain of the white biotechnology industry.

With this background, Enzymicals AG is the right partner for your biotechnological projects.

The team of Enzymicals AG is always available for the solution of your task.